GE Healthcare using AI for COVID-19 chest x-rays
GE Healthcare has announce d a suite of AI algorithms intended to lessen the clinical strain caused by COVID-19.
GE Healthcare is a subsidiary of General Electri c, the American conglomerate, and is focused on the healthcare and pharmaceutical industry.
The eight algorithms, from Lunit INSIGHT CXR, are capable of analysing chest x-rays to find abnormalities such as tuberculosis, lung nodules and pneumonia, an indicator of COVID-19 and a key cause of mortality in those who have contracted coronavirus.
In a press release, Kieran Murphy, President and CEO, GE Healthcare, said: “The launch of our Thoracic Care Suite is a part of GE Healthcare’s larger effort to help ensure clinicians and partners on the front lines have the equipment they need to quickly diagnose and effectively treat COVID-19 patients.
“The pandemic has proven that data, analytics, AI and connectivity will only become more central to delivering care. For GE Healthcare, that means continuing to advance intelligent health and providing innovative technologies. This new offering is the latest example of how x-ray and AI can uphold the highest standard of patient care amidst the most modern of disease threats.”
GE Healthcare highlighted the urgency of automation in the face of increasingly large numbers of infected individuals, threatening to overwhelm healthcare facilities and professionals. Radiologists face a particular squeeze to process and understand x-rays, with GE saying that even prior to the ongoing pandemic, with approximately 1.44 billion chest x-ray exams happening per year.
“Clinicians are looking for clinically proven methods to help identify symptoms early and determine which patients are at higher risk of complications and need to be actively monitored,” saidProfessor Fergus Gleeson, Consultant Radiologist, Professor of Radiology at the University of Oxford. “AI can help identify these distinctions and enable hospital resources to be targeted to those that will need them whilst in hospital and following discharge.”
(Image: GE Healthcare)
Vaccine rollout spurring dark net activity, McAfee finds
A report by security software company McAfee has found a huge rise in the availability and demand for illegal COVID-19 vaccines.
The research by McAfee Advanced Threat Research found evidence that COVID-19 vaccines are currently available on at least a dozen dark net marketplaces. Vaccines allegedly made by Pfizer-BioNTech are being sold for $600 to $2,500 per dose, with vendors using channels such as Wickr, Telegram, WhatsApp and Gmail to advertise and communicate.
Some of the supposed vaccines are imported from the US, while others are packed in the UK and shipped all over the world, according to the listings.
Moderna vaccines, potentially fraudulent antibody tests and fake vaccine cards are also being increasingly sold on the dark web, on at least 10 different underground markets.
Anne An, senior security researcher at McAfee’s Advanced Programs Group, told us that with the increased global demand for COVID-19 vaccinations, the demand for illegal vaccines, fake test results and vaccination record cards has also grown. "Consumers who are buying these items pose a serious threat to public health and spur the underground economy" she said.
"Opportunistic cybercriminals capitalise on public interest in obtaining a COVID-19 immunity passport. These bad actors can also benefit by reselling the names, dates of birth, home addresses, contact details and other personally indefinable information of their customers."
As well as cyber security measures, An says education is necessary to stem the rise in these illegal sales. "Dark net selling of illegal COVID-19 vaccinations, fake test results and vaccination record cards is both a cybersecurity issue and an educational issue.
"On the one hand, channels being used as a means of business have the responsibility to monitor and mitigate cybercriminal activity on their platforms. On the other, the ongoing efforts of government and medical officials to provide factual information on COVID-19 and vaccinations is critical to discouraging the demand for fraudulent alternatives."
Read McAfee's report Fool’s Gold”: Questionable Vaccines, Bogus Results, and Forged Cards